|
⚲
|
| Keyboard |
| Sabby Management LLC
✚
|
|
|---|---|
| CRD # | 162659 |
| SEC # | 801-78289 |
| CIK # | 0001535610 |
| AUM | |
| Employees | 5 (40% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 646-307-4500 |
| Address | 115 Hidden Hills Dr Spicewood, TX 78669 |
| Source | [IAPD] [EDGAR] |
| Total AUM ($M) |
|---|
| Fees and Compensation — Form ADV Part 2A (3/14/2023) [Brochure] |
|---|
ITEM 5 – FEES AND COMPENSATION Sabby does not have a standardized fee schedule for its discretionary investment management services. Sabby generally receives a management fee of 2% per annum of assets under management, which is charged quarterly in advance. Sabby Capital also may receive performance-based compensation of up to 20% of the increase (or 27.5% of the increase over a “hurdle” rate) in net asset value of an investment in a Private Fund above a “high water mark” (i.e., the previous highest net asset value at which performance-based compensation was paid). Performance-based compensation generally is charged annually in arrears and upon an intra-year redemption by an investor in a Private Fund (where permitted). This performance-based compensation is calculated taking into account both realized and unrealized gains for certain of the Private Funds and for solely realized gains for the balance of the Private Funds. Sabby Capital holds a membership interest in, and class of shares of, certain of the Private Funds managed by Sabby and receives the performance-based compensation described above through an allocation of net profits from such Private Funds in respect of such interest and shares. Fees and other material terms regarding an investment in a particular Private Fund are set forth in such Private Fund’s Memorandum. Fees may be reduced or waived in certain circumstances or with respect to certain investors (e.g., principals and employees of Sabby). Fees charged with respect to an investment in a Private Fund advised by Sabby are set forth in such Private Fund’s Memorandum. While investors in certain Private Funds may terminate Sabby’s advisory services at the end of any calendar quarter without penalty generally upon forty-five days’ prior written notice, withdrawals and redemptions by investors in such Private Funds have been suspended as it has been determined to dissolve those Private Fund in an orderly manner, and investors have received a mandatory withdrawal or redemption on a quarterly basis as assets of those Private Funds have been liquidated. Investors in other Private Funds commit their capital for a specific period of time, generally a period of approximately five years, and are not permitted to withdraw or redeem their investments. Investors in such Private Funds instead generally receive distributions at the end of the second, third and fourth years of their investment, with the balance distributed upon the end of the the fifth year. Upon termination of any investment in a Private Fund, any prepaid, unearned fees will be promptly refunded and any earned, unpaid fees will be due and payable. Sabby’s fees do not include brokerage and transaction fees, costs and charges, and other related costs and expenses that will be incurred regarding the trading and maintenance of the Private Funds. Private Funds may incur certain charges imposed by custodians, brokers and other third parties such as commissions, custodial fees, and other fees and taxes on brokerage accounts and securities transactions. Such charges, fees and commissions are exclusive of and in addition to Sabby’s fees, and Sabby does not receive any portion of these commissions, fees, and costs. Item 12 describes the factors that Sabby considers in selecting broker-dealers for Private Fund transactions and determining the reasonableness of their compensation (e.g., commissions). |
| Account Minimums and Types of Clients — Form ADV Part 2A (3/14/2023) [Brochure] |
|---|
ITEM 7 – TYPES OF CLIENTS Sabby provides investment advice to U.S. and non-U.S. institutional clients consisting solely of Private Funds. While Sabby does not have a standard minimum account size, each of the Private Funds has a $500,000 minimum investment, which minimum has been waived from time to time. |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Briacell Therapeutics Corp | 0.4 | ||
| SenesTech Inc | 0.4 | ||
| Big Tree Cloud Holdings Ltd | 0.3 | ||
| Briacell Therapeutics Corp | 0.3 | ||
| Tuanche Ltd | 0.2 | ||
| POP Culture Group Co Ltd | 0.2 | ||
| Moleculin Biotech Inc | 0.2 | ||
| Midatech Pharma PLC | 0.2 | ||
| Arcadia Biosciences Inc | 0.2 | ||
| Tanzanian Royalty Exploration Corp | 0.1 | ||
| View All | |||
| Holdings by Sector ($M) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | BAM Opportunity Fund SPV LLC | [2012-04-11] | 0.0 M | 14.3 M |
| Filed 2010-06-03 (D) · Exemption 506, 3(c)(7) · Minimum $500,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | Sabby Healthcare Master Fund Ltd | [2012-04-11] | 0.4 M | 15.8 M |
| Filed 2012-03-14 (D) · Exemption 506, 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets $25,000,001 - $50,000,000 | ||||
| PE | Sabby Volatility Warrant Master Fund Ltd | [2012-04-11] | 7.1 M | 181.5 M |
| Filed 2019-02-04 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Revenue $25,000,001 - $100,000,000 | ||||
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 2 | 223.5 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 2 | 223.5 |
| By Discretionary | ||
| Discretionary | 2 | 223.5 |
| Non-Discretionary | 0 | 0.0 |
| Total | 2 | 223.5 |
| By Non-United States Persons | ||
| Non-United States Persons | 41.7 | |
| United States Persons | 181.8 | |
| Total | 2 | 223.5 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Ross Berman | Promoter | 9 | 3 | |
| Hal Mintz | Promoter | 8 | 2 | |
| Harry Thompson | Director | 6 | 2 | |
| Bam Management LLC | Executive Officer | 2 | 2 | |
| Noella Thompson | Director | 2 | 2 | |
| Vick Chapman | Director | 1 | 1 | |
| Joseph McIvor | Director | 1 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001535610] | |
| 3 | [0001535610] | |
| 4 | [0001535610] | |
| SC 13D | [0001535610] | |
| SC 13G | [0001535610] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Hedge Fund, Private Equity |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Sabby Management LLC | |
| Empery Digital Inc | |
| Rosetta Genomics Ltd | |
| EnteroMedics Inc | |
| Sabby Healthcare Master Fund Ltd | |
| Morria Biopharmaceuticals PLC | |
| Mintz Hal | |
| Nupathe Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Empery Digital Inc VLCN
Common Stock
|
2024-10-15 | Other | 774,569 | ||
|
Empery Digital Inc VLCN
Prefunded Warrant (Right to Buy) · derivative
|
2024-10-15 | Other | 774,569 | ||
|
Empery Digital Inc VLCN
Common Stock
|
2024-08-30 | Buy | 10,000 | $1.42 | 14,200 |
|
Empery Digital Inc VLCN
Common Stock
|
2024-08-29 | Buy | 3,064 | $1.45 | 4,443 |
|
Empery Digital Inc VLCN
Common Stock
|
2024-08-28 | Buy | 21,998 | $1.50 | 32,997 |
|
Empery Digital Inc VLCN
Common Stock
|
2024-08-26 | Buy | 3,194 | $1.55 | 4,951 |
|
Empery Digital Inc VLCN
Common Stock
|
2024-08-23 | Buy | 3,500 | $1.55 | 5,425 |
|
Empery Digital Inc VLCN
Common Stock
|
2024-08-22 | Sell | 32,794 | $2.05 | 67,228 |
|
Empery Digital Inc VLCN
Common Stock
|
2024-08-22 | Buy | 3,598 | $1.49 | 5,361 |
|
Empery Digital Inc VLCN
Common Stock
|
2024-08-21 | Buy | 17,757 | $1.50 | 26,636 |
|
Empery Digital Inc VLCN
Common Stock
|
2024-08-20 | Buy | 10,953 | $1.57 | 17,196 |
|
Empery Digital Inc VLCN
Common Stock
|
2024-08-19 | Buy | 5,065 | $1.59 | 8,053 |
|
Empery Digital Inc VLCN
Common Stock
|
2024-08-16 | Buy | 16,974 | $1.43 | 24,273 |
|
Empery Digital Inc VLCN
Common Stock
|
2024-08-15 | Buy | 27,514 | $1.51 | 41,546 |
|
Empery Digital Inc VLCN
Common Stock
|
2024-08-14 | Buy | 20,158 | $1.62 | 32,656 |
|
Empery Digital Inc VLCN
Common Stock
|
2024-08-13 | Buy | 3,372 | $1.68 | 5,665 |
|
Empery Digital Inc VLCN
Common Stock
|
2024-08-12 | Buy | 6,087 | $1.64 | 9,983 |
|
Empery Digital Inc VLCN
Common Stock
|
2024-08-09 | Buy | 7,116 | $1.64 | 11,670 |
|
Empery Digital Inc VLCN
Common Stock
|
2024-08-08 | Buy | 8,019 | $1.65 | 13,231 |
|
Empery Digital Inc VLCN
Common Stock
|
2024-08-07 | Buy | 43,756 | $1.76 | 77,011 |
| showing 20 of 90 most recent transactions | |||||